Dynamic comparison of early immune reactions and immune cell reconstitution after umbilical cord blood transplantation and peripheral blood stem cell transplantation

Umbilical cord blood transplantation (UCBT) and peripheral blood stem cell transplantation (PBSCT) are effective allogeneic treatments for patients with malignant and non-malignant refractory hematological diseases. However, the differences in the immune cell reconstitution and the immune reactions...

Full description

Bibliographic Details
Main Authors: Xuxu Zhao, Wenya Wang, Shiqin Nie, Liangquan Geng, Kaidi Song, Xinyi Zhang, Wen Yao, Ping Qiang, Guangyu Sun, Dongyao Wang, Huilan Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1084901/full
_version_ 1827969720123392000
author Xuxu Zhao
Xuxu Zhao
Wenya Wang
Wenya Wang
Shiqin Nie
Shiqin Nie
Liangquan Geng
Kaidi Song
Xinyi Zhang
Wen Yao
Ping Qiang
Guangyu Sun
Dongyao Wang
Dongyao Wang
Dongyao Wang
Huilan Liu
Huilan Liu
Huilan Liu
author_facet Xuxu Zhao
Xuxu Zhao
Wenya Wang
Wenya Wang
Shiqin Nie
Shiqin Nie
Liangquan Geng
Kaidi Song
Xinyi Zhang
Wen Yao
Ping Qiang
Guangyu Sun
Dongyao Wang
Dongyao Wang
Dongyao Wang
Huilan Liu
Huilan Liu
Huilan Liu
author_sort Xuxu Zhao
collection DOAJ
description Umbilical cord blood transplantation (UCBT) and peripheral blood stem cell transplantation (PBSCT) are effective allogeneic treatments for patients with malignant and non-malignant refractory hematological diseases. However, the differences in the immune cell reconstitution and the immune reactions during initial stages post-transplantation are not well established between UCBT and PBSCT. Therefore, in this study, we analyzed the differences in the immune reactions during the early stages (days 7-100 post-transplantation) such as pre-engraftment syndrome (PES), engraftment syndrome (ES), and acute graft-versus-host disease (aGVHD) and the immune cell reconstitution between the UCBT and the PBSCT group of patients. We enrolled a cohort of patients that underwent UCBT or PBSCT and healthy controls (n=25 each) and evaluated their peripheral blood mononuclear cell (PBMC) samples and plasma cytokine (IL-10 and GM-CSF) levels using flow cytometry and ELISA, respectively. Our results showed that the incidences of early immune reactions such as PES, ES, and aGVHD were significantly higher in the UCBT group compared to the PBSCT group. Furthermore, in comparison with the PBSCT group, the UCBT group showed higher proportion and numbers of naïve CD4+ T cells, lower proportion and numbers of Tregs, higher proportion of CD8+ T cells with increased activity, and higher proportion of mature CD56dim CD16+ NK cells during the early stages post-transplantation. Moreover, the plasma levels of GM-CSF were significantly higher in the UCBT group compared to the PBSCT group in the third week after transplantation. Overall, our findings demonstrated significant differences in the post-transplantation immune cell reconstitution between the UCBT and the PBSCT group of patients. These characteristics were associated with significant differences between the UCBT and the PBSCT groups regarding the incidences of immune reactions during the early stages post transplantation.
first_indexed 2024-04-09T18:42:00Z
format Article
id doaj.art-a6c8b172acdd4086bbb3f9ca6c38387e
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-09T18:42:00Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-a6c8b172acdd4086bbb3f9ca6c38387e2023-04-11T04:28:55ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-04-011410.3389/fimmu.2023.10849011084901Dynamic comparison of early immune reactions and immune cell reconstitution after umbilical cord blood transplantation and peripheral blood stem cell transplantationXuxu Zhao0Xuxu Zhao1Wenya Wang2Wenya Wang3Shiqin Nie4Shiqin Nie5Liangquan Geng6Kaidi Song7Xinyi Zhang8Wen Yao9Ping Qiang10Guangyu Sun11Dongyao Wang12Dongyao Wang13Dongyao Wang14Huilan Liu15Huilan Liu16Huilan Liu17Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaBlood and Cell Therapy Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaDepartment of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaBlood and Cell Therapy Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaDepartment of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaBlood and Cell Therapy Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaDepartment of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaDepartment of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaDepartment of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaDepartment of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaDepartment of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaDepartment of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaDepartment of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaBlood and Cell Therapy Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaAnhui Province Key Laboratory of Immunology in Chronic Diseases, Bengbu Medical College, Bengbu, Anhui, ChinaDepartment of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaBlood and Cell Therapy Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaDepartment of Transfusion, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, ChinaUmbilical cord blood transplantation (UCBT) and peripheral blood stem cell transplantation (PBSCT) are effective allogeneic treatments for patients with malignant and non-malignant refractory hematological diseases. However, the differences in the immune cell reconstitution and the immune reactions during initial stages post-transplantation are not well established between UCBT and PBSCT. Therefore, in this study, we analyzed the differences in the immune reactions during the early stages (days 7-100 post-transplantation) such as pre-engraftment syndrome (PES), engraftment syndrome (ES), and acute graft-versus-host disease (aGVHD) and the immune cell reconstitution between the UCBT and the PBSCT group of patients. We enrolled a cohort of patients that underwent UCBT or PBSCT and healthy controls (n=25 each) and evaluated their peripheral blood mononuclear cell (PBMC) samples and plasma cytokine (IL-10 and GM-CSF) levels using flow cytometry and ELISA, respectively. Our results showed that the incidences of early immune reactions such as PES, ES, and aGVHD were significantly higher in the UCBT group compared to the PBSCT group. Furthermore, in comparison with the PBSCT group, the UCBT group showed higher proportion and numbers of naïve CD4+ T cells, lower proportion and numbers of Tregs, higher proportion of CD8+ T cells with increased activity, and higher proportion of mature CD56dim CD16+ NK cells during the early stages post-transplantation. Moreover, the plasma levels of GM-CSF were significantly higher in the UCBT group compared to the PBSCT group in the third week after transplantation. Overall, our findings demonstrated significant differences in the post-transplantation immune cell reconstitution between the UCBT and the PBSCT group of patients. These characteristics were associated with significant differences between the UCBT and the PBSCT groups regarding the incidences of immune reactions during the early stages post transplantation.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1084901/fullUCBTPBSCTGvHDimmune cell reconstitutionimmune reactions
spellingShingle Xuxu Zhao
Xuxu Zhao
Wenya Wang
Wenya Wang
Shiqin Nie
Shiqin Nie
Liangquan Geng
Kaidi Song
Xinyi Zhang
Wen Yao
Ping Qiang
Guangyu Sun
Dongyao Wang
Dongyao Wang
Dongyao Wang
Huilan Liu
Huilan Liu
Huilan Liu
Dynamic comparison of early immune reactions and immune cell reconstitution after umbilical cord blood transplantation and peripheral blood stem cell transplantation
Frontiers in Immunology
UCBT
PBSCT
GvHD
immune cell reconstitution
immune reactions
title Dynamic comparison of early immune reactions and immune cell reconstitution after umbilical cord blood transplantation and peripheral blood stem cell transplantation
title_full Dynamic comparison of early immune reactions and immune cell reconstitution after umbilical cord blood transplantation and peripheral blood stem cell transplantation
title_fullStr Dynamic comparison of early immune reactions and immune cell reconstitution after umbilical cord blood transplantation and peripheral blood stem cell transplantation
title_full_unstemmed Dynamic comparison of early immune reactions and immune cell reconstitution after umbilical cord blood transplantation and peripheral blood stem cell transplantation
title_short Dynamic comparison of early immune reactions and immune cell reconstitution after umbilical cord blood transplantation and peripheral blood stem cell transplantation
title_sort dynamic comparison of early immune reactions and immune cell reconstitution after umbilical cord blood transplantation and peripheral blood stem cell transplantation
topic UCBT
PBSCT
GvHD
immune cell reconstitution
immune reactions
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1084901/full
work_keys_str_mv AT xuxuzhao dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT xuxuzhao dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT wenyawang dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT wenyawang dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT shiqinnie dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT shiqinnie dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT liangquangeng dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT kaidisong dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT xinyizhang dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT wenyao dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT pingqiang dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT guangyusun dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT dongyaowang dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT dongyaowang dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT dongyaowang dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT huilanliu dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT huilanliu dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation
AT huilanliu dynamiccomparisonofearlyimmunereactionsandimmunecellreconstitutionafterumbilicalcordbloodtransplantationandperipheralbloodstemcelltransplantation